109 related articles for article (PubMed ID: 26217978)
1. Antagonism of quercetin against tremor induced by unilateral striatal lesion of 6-OHDA in rats.
Mu X; Yuan X; Du LD; He GR; Du GH
J Asian Nat Prod Res; 2016; 18(1):65-71. PubMed ID: 26217978
[TBL] [Abstract][Full Text] [Related]
2. Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures.
Kääriäinen TM; Piltonen M; Ossola B; Kekki H; Lehtonen S; Nenonen T; Lecklin A; Raasmaja A; Männistö PT
Brain Res; 2008 Apr; 1203():149-59. PubMed ID: 18329008
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect of bioflavonoid quercetin in 6-hydroxydopamine-induced oxidative stress biomarkers in the rat striatum.
Haleagrahara N; Siew CJ; Mitra NK; Kumari M
Neurosci Lett; 2011 Aug; 500(2):139-43. PubMed ID: 21704673
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.
Yuan H; Sarre S; Ebinger G; Michotte Y
Brain Res; 2004 Nov; 1026(1):95-107. PubMed ID: 15476701
[TBL] [Abstract][Full Text] [Related]
5. Nicotine alters striatal glutamate function and decreases the apomorphine-induced contralateral rotations in 6-OHDA-lesioned rats.
Meshul CK; Kamel D; Moore C; Kay TS; Krentz L
Exp Neurol; 2002 May; 175(1):257-74. PubMed ID: 12009777
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats.
Jin F; Wu Q; Lu YF; Gong QH; Shi JS
Eur J Pharmacol; 2008 Dec; 600(1-3):78-82. PubMed ID: 18940189
[TBL] [Abstract][Full Text] [Related]
7. Effect of quercetin and desferrioxamine on 6-hydroxydopamine (6-OHDA) induced neurotoxicity in striatum of rats.
Haleagrahara N; Siew CJ; Ponnusamy K
J Toxicol Sci; 2013 Feb; 38(1):25-33. PubMed ID: 23358137
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effect of BDNF in young and aged 6-OHDA treated rat model of Parkinson disease.
Singh S; Ahmad R; Mathur D; Sagar RK; Krishana B
Indian J Exp Biol; 2006 Sep; 44(9):699-704. PubMed ID: 16999024
[TBL] [Abstract][Full Text] [Related]
9. Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity.
Dabbeni-Sala F; Di Santo S ; Franceschini D; Skaper SD; Giusti P
FASEB J; 2001 Jan; 15(1):164-170. PubMed ID: 11149904
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effect of hydroxysafflor yellow A on 6-hydroxydopamine-induced Parkinson's disease in rats.
Han B; Hu J; Shen J; Gao Y; Lu Y; Wang T
Eur J Pharmacol; 2013 Aug; 714(1-3):83-8. PubMed ID: 23791614
[TBL] [Abstract][Full Text] [Related]
11. Lesion of subthalamic or motor thalamic nucleus in 6-hydroxydopamine-treated rats: effects on striatal glutamate and apomorphine-induced contralateral rotations.
Touchon JC; Moore C; Frederickson J; Meshul CK
Synapse; 2004 Mar; 51(4):287-98. PubMed ID: 14696016
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of interleukin-1 receptor 1 is not neuroprotective in the 6-hydroxydopamine striatal lesion rat model of Parkinson's disease.
Walsh S; Gavin A; Wyatt S; O'Connor C; Keeshan K; Nolan YM; O'Keeffe GW; Sullivan AM
Int J Neurosci; 2015 Jan; 125(1):70-7. PubMed ID: 24628580
[TBL] [Abstract][Full Text] [Related]
13. Effects of the hook of Uncaria rhynchophylla on neurotoxicity in the 6-hydroxydopamine model of Parkinson's disease.
Shim JS; Kim HG; Ju MS; Choi JG; Jeong SY; Oh MS
J Ethnopharmacol; 2009 Nov; 126(2):361-5. PubMed ID: 19703534
[TBL] [Abstract][Full Text] [Related]
14. Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions.
Machado-Filho JA; Correia AO; Montenegro AB; Nobre ME; Cerqueira GS; Neves KR; Naffah-Mazzacoratti Mda G; Cavalheiro EA; de Castro Brito GA; de Barros Viana GS
Behav Brain Res; 2014 May; 264():116-25. PubMed ID: 24525422
[TBL] [Abstract][Full Text] [Related]
15. Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro.
Mu X; He G; Cheng Y; Li X; Xu B; Du G
Pharmacol Biochem Behav; 2009 Jun; 92(4):642-8. PubMed ID: 19327378
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective and behavioural assessments of an imidazolium compound (DBZIM) in a rat model of Parkinson's disease induced by 6-OHDA.
Chan HH; Kumar S; Zhuo L
Eur J Pharmacol; 2013 Sep; 715(1-3):405-13. PubMed ID: 23652161
[TBL] [Abstract][Full Text] [Related]
18. The beneficial effect of vanillin on 6-hydroxydopamine rat model of Parkinson's disease.
Abuthawabeh R; Abuirmeileh AN; Alzoubi KH
Restor Neurol Neurosci; 2020; 38(5):369-373. PubMed ID: 32986633
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson's disease.
Agnati LF; Leo G; Vergoni AV; Martínez E; Hockemeyer J; Lluis C; Franco R; Fuxe K; Ferré S
Brain Res Bull; 2004 Aug; 64(2):155-64. PubMed ID: 15342103
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective Activities of Spirulina platensis in the 6-OHDA Model of Parkinson's Disease Are Related to Its Anti-Inflammatory Effects.
Lima FAV; Joventino IP; Joventino FP; de Almeida AC; Neves KRT; do Carmo MR; Leal LKAM; de Andrade GM; de Barros Viana GS
Neurochem Res; 2017 Dec; 42(12):3390-3400. PubMed ID: 28861668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
